| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 14 | +42.86% | -0.59% | +0.22% | -0.81% | +0.10% | — |
| 14d | 14 | +57.14% | -2.27% | +0.90% | -3.17% | -2.42% | — |
| 30d | 14 | +64.29% | +2.44% | +1.27% | +1.17% | -3.50% | — |
| 60d | 14 | +42.86% | +5.24% | +3.07% | +2.17% | -1.66% | — |
| 90d | 14 | +38.46% | +1.30% | +6.14% | -4.64% | -8.54% | — |
| 180d | 14(1 pending) | +58.33% | +4.03% | +10.63% | -6.53% | -17.05% | — |
| 1y | 14(3 pending) | +60.00% | -11.60% | +18.80% | -29.79% | -33.66% | — |
| 2y | 14(7 pending) | +50.00% | +3.69% | +27.90% | -21.83% | -8.19% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 72,694 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 25,816 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 40,565 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 309,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 5,250 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 65,625 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 8,889 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 90,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 105,000 | — | — | 0 | Apr 23, 2026 | Apr 23, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 6,395 | $11.60 | $74.2K | 72,694 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 4,375 | — | — | 79,089 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,687 | — | — | 74,714 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 2,963 | — | — | 65,589 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 1,750 | — | — | 5,250 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,688 | — | — | 71,027 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 1,750 | — | — | 67,339 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,688 | — | — | 25,816 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,687 | — | — | 40,565 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 2,963 | — | — | 8,889 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 4,375 | — | — | 65,625 | Feb 15, 2026 | Feb 18, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 105,000 | — | — | 105,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 4,319 | $8.91 | $38.5K | 62,626 | Nov 17, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 1,750 | — | — | 7,000 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 2,963 | — | — | 11,852 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,687 | — | — | 63,258 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 2,963 | — | — | 57,821 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,687 | — | — | 44,252 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 1,750 | — | — | 59,571 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,687 | — | — | 29,504 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,687 | — | — | 66,945 | Nov 15, 2025 | Nov 18, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 90,000 | — | — | 0 | Nov 6, 2025 | Nov 7, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Nov 6, 2025 | Nov 7, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 309,000 | — | — | 309,000 | Nov 6, 2025 | Nov 7, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 4,365 | $6.77 | $29.5K | 54,858 | Aug 18, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 1,750 | — | — | 8,750 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 1,750 | — | — | 51,849 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 2,963 | — | — | 50,099 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 2,963 | — | — | 14,815 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,687 | — | — | 59,223 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE Gen Counsel & Secretary | 3,687 | — | — | 55,536 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,687 | — | — | 33,191 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE Gen Counsel & Secretary | 3,687 | — | — | 47,939 | Aug 15, 2025 | Aug 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 4,552 | $6.26 | $28.5K | 47,136 | May 16, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 51,688 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 42,564 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 48,001 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 36,878 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 51,626 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 44,314 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 10,500 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 17,778 | May 15, 2025 | May 19, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 4,646 | $11.96 | $55.6K | 39,602 | Feb 18, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 55,313 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 40,565 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 12,250 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 20,740 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 36,874 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 44,248 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 35,124 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 40,561 | Feb 15, 2025 | Feb 21, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 59,000 | — | — | 59,000 | Jan 15, 2025 | Jan 31, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Jan 15, 2025 | Jan 31, 2025 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,165 | $13.21 | $41.8K | 32,162 | Nov 18, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 23,702 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 31,640 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 29,890 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 35,327 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 44,252 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 14,000 | Nov 15, 2024 | Nov 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,202 | $14.00 | $44.8K | 26,928 | Aug 16, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 30,130 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 15,750 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 26,443 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 26,664 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 47,939 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 24,693 | Aug 15, 2024 | Aug 19, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,253 | $16.08 | $52.3K | 21,731 | May 16, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 24,984 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 17,500 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 29,626 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 19,547 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 51,626 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 21,297 | May 15, 2024 | May 17, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,242 | $15.25 | $49.4K | 16,585 | Feb 16, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 2,962 | — | — | 14,390 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 2,962 | — | — | 32,588 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 3,687 | — | — | 19,827 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 1,750 | — | — | 19,250 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE GENERAL COUNSEL | 1,750 | — | — | 16,140 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE GENERAL COUNSEL | 3,687 | — | — | 55,313 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Jan 5, 2024 | Jan 9, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 59,000 | — | — | 59,000 | Jan 5, 2024 | Jan 9, 2024 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE General Counsel | 5,313 | $11.69 | $62.1K | 11,428 | Nov 16, 2023 | Nov 17, 2023 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE General Counsel | 11,850 | — | — | 14,991 | Nov 15, 2023 | Nov 17, 2023 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE General Counsel | 11,850 | — | — | 35,550 | Nov 15, 2023 | Nov 17, 2023 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | PURCHASE General Counsel | 1,750 | — | — | 16,741 | Nov 15, 2023 | Nov 17, 2023 ↗ | View → |
| DAWN DAY ONE BIOPHARMACEUTICALS, INC. | SALE General Counsel | 1,750 | — | — | 21,000 | Nov 15, 2023 | Nov 17, 2023 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 2,466 | $67.90 | $167.4K | 13,777.152 | Jul 30, 2021 | Aug 3, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 3,119 | $64.21 | $200.3K | 16,243.152 | May 5, 2021 | May 7, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 152 | $60.93 | $9.3K | 15,516.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 2,495 | — | — | 19,811.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASEGRANT Stock grant | 5,972 | — | — | 5,972 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 36 | — | — | 15,895.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 980 | — | — | 17,611.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 30 | — | — | 15,668.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 452 | — | — | 0 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 391 | $60.93 | $23.8K | 16,631.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 2,495 | — | — | 0 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 313 | $60.93 | $19.1K | 17,316.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 486 | — | — | 20,297.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 980 | — | — | 2,943 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 1,062 | — | — | 16,838.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 415 | — | — | 418 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 935 | $60.93 | $57.0K | 19,362.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 119 | $60.93 | $7.3K | 15,776.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 184 | — | — | 17,022.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 452 | — | — | 15,638.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 18 | — | — | 17,629.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 1,062 | — | — | 2,124 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASEGRANT Stock grant | 3,981 | — | — | 3,981 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 415 | — | — | 15,931.152 | Mar 10, 2021 | Mar 12, 2021 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 900 | $63.39 | $57.1K | 15,186.152 | Nov 24, 2020 | Nov 25, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 3,200 | $61.01 | $195.2K | 16,086.152 | May 22, 2020 | May 26, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 451 | — | — | 452 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 6 | — | — | 16,115.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 51 | — | — | 16,484.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 272 | — | — | 20,363.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 133 | $57.93 | $7.7K | 15,982.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 372 | — | — | 16,121.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 182 | $57.93 | $10.5K | 16,302.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 238 | — | — | 17,854.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASEGRANT Stock grant | 5,885 | — | — | 5,885 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 1,062 | — | — | 3,186 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 451 | — | — | 16,433.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASEGRANT Stock grant | 3,923 | — | — | 3,923 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 2,707 | — | — | 20,091.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 2,707 | — | — | 0 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 470 | $57.93 | $27.2K | 17,384.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 372 | — | — | 0 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 415 | — | — | 833 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 415 | — | — | 16,717.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 143 | $57.93 | $8.3K | 16,554.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 20 | — | — | 16,697.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | SALE SVP,ChiefCompliance&EthicsOff. | 1,077 | $57.93 | $62.4K | 19,286.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |
| BMY BRISTOL MYERS SQUIBB CO | PURCHASE SVP,ChiefCompliance&EthicsOff. | 1,062 | — | — | 17,616.152 | Mar 10, 2020 | Mar 12, 2020 ↗ | View → |